MIMOSA Diagnostics

MIMOSA Diagnostics is a company that develops a mobile health platform using near-infrared light to non-invasively assess tissue health. It leverages multi-spectral mobile tissue analysis for remote monitoring and assessment, supporting treatment decisions, and outcomes for a patient. The company focuses on diabetes as the leading cause of non-traumatic lower limb amputation.